Evidence map›Paper›PMID 38689516›Full record

ArticleAging cell2024

Cellular senescence is a double-edged sword in regulating aged immune responses to influenza.

Blake L Torrance, Andreia N Cadar, Hunter A Panier, Dominique E Martin, Erica C Lorenzo, Evan R Jellison, Jenna M Bartley, Laura Haynes

Abstract read
In one paragraph

Article in Aging cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. ApoD mediates age-associated increase in vulnerability to influenza virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Senotherapy for chronic lung disease.Pharmacological reviews · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Blake L TorranceUConn Center on Aging, University of Connecticut School of Medicine, Farmington, Connecticut, USA.ORCID 0000-0001-8647-2436
Andreia N CadarUConn Center on Aging, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Hunter A PanierDepartment of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Dominique E MartinUConn Center on Aging, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Erica C LorenzoUConn Center on Aging, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Evan R JellisonDepartment of Immunology, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Jenna M BartleyUConn Center on Aging, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Laura HaynesUConn Center on Aging, University of Connecticut School of Medicine, Farmington, Connecticut, USA.ORCID 0000-0002-5006-3339

Funding

Research Education ComponentP30AG067988 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Richard H Fortinsky, GEORGE A KUCHEL · 2021 to 2026
$9.5M
Impact of Senolytics on Aged Vaccine ResponsesR01AI173305 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Jenna Bartley · 2023 to 2026
$1.7M
Regenerative Engineering of Musculoskeletal Tissues- a Convergence Doctoral Training ProgramT32AR079114 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LAURENCIN, CATO T. · 2021 to 2025
$1.1M
The impact of senescence on immune memoryR21AG081678 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HAYNES, LAURA · 2023 to 2023
$453k
Can Senolytics Improve the Aged Response to Viral InfectionR21AG071292 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HAYNES, LAURA, XU, MING · 2021 to 2022
$451k
American Federation for Aging Research Diana Jacobs Kalman Scholarship for Research in thNational Institute of Allergy and Infectious Diseases R01AI173305NIAID NIH HHS R01 AI173305NIAMS NIH HHS T32 AR079114NIAMS NIH HHS T32AR079114NIA NIH HHS P30 AG067988NIA NIH HHS P30AG067988NIA NIH HHS R21 AG071292NIA NIH HHS R21AG071292NIA NIH HHS R21 AG081678NIA NIH HHS R21AG081678
6 · The paper itself

Abstract

Clearance of senescent cells has demonstrated therapeutic potential in the context of chronic age-related diseases. Little is known, however, how clearing senescent cells affects the ability to respond to an acute infection and form quality immunological memory. We aimed to probe the effects of clearing senescent cells in aged mice on the immune response to influenza (flu) infection. We utilized a p16 trimodality reporter mouse model (p16-3MR) to allow for identification and selective clearance of p16-expressing cells upon administration of ganciclovir (GCV). While p16-expressing cells may exacerbate dysfunctional responses to a primary infection, our data suggest they may play a role in fostering memory cell generation. We demonstrate that although clearance of p16-expressing cells enhanced viral clearance, this also severely limited antibody production in the lungs of flu-infected aged mice. 30 days later, there were fewer flu-specific CD8 memory T cells and lower levels of flu-specific antibodies in the lungs of GCV-treated mice. Furthermore, GCV-treated mice were unable to mount an optimal memory response and demonstrated increased viral load following heterosubtypic challenge. These results suggest that targeting senescent cells may potentiate primary responses while limiting the ability to form durable and protective immune memory with age.

Indexed as

Cellular SenescenceOrthomyxoviridae InfectionsAgingAnimalsInfluenza, HumanMiceMice, Inbred C57BLaginginfluenzamemoryp16senescenceT cells

Identifiers

PMID38689516
PMCPMC11258475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.